If you've been diagnosed with multiple sclerosis (MS), it's time to start exploring treatment options. You've got a lot of them, everything from disease-modifying therapies and drugs that help manage ...

Journal of Nuclear Medicine January 2025, jnumed.124.268242; DOI: https://doi.org/10.2967/jnumed.124.268242 ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

While there’s no cure for multiple sclerosis (MS), there are many treatments available. These treatments mainly focus on slowing down the progression of the disease and managing symptoms.

When it comes to the outlook for multiple sclerosis (MS), there’s both good news and bad news. Although MS isn’t fatal, there’s currently no cure — MS is a chronic condition. But many ...

To use and configure, check out the setup documentation. For advanced usage, check out the configuration reference and custom instrumentation API. Confused about the terminology of APM? Take a look at ...

In multiple sclerosis (MS), a person's immune system attacks the protective covering (myelin sheath) of nerve fibers in the brain and spinal cord (central nervous system). MS disease-modifying ...

Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances.

Reopening old nuclear plants can only go so far. This article is from The Spark, MIT Technology Review’s weekly climate newsletter. To receive it in your inbox every Wednesday, sign up here.

The International Nuclear Safety Advisory Group (INSAG) is a group of experts with high professional competence in the field of nuclear and radiation safety and experience of working in regulatory ...

The company has successfully trialed a nuclear fuel that could one day drastically cut down the travel time to Mars and beyond. The tests showed the fuel can withstand the harsh conditions of a ...

Enigma Biomedical has entered into an agreement with Neuraly to use its PET imaging tracer PMI04 to visualize ... diseases such as multiple sclerosis (MS). Microglia are resident immune cells ...